Clinical trials are complex and generate extensive data during the entire clinical lifecycle. This means that clinical trial analytics is a vital function for many modern medical and pharmaceutical organisations. Consequently, a lot of time is spent on the collection, validation, and processing of diverse data to analyse the effectiveness of pharmaceutical products, while taking into consideration various factors.
Clinical trial analytics services enable stakeholders to perform a comprehensive review and analytical testing of the drug product. The data provides valuable information required for future drug development and can be used to bring products to the market faster.
Analytical testing can be applied to a range of drug products such as small molecules, peptides and biologics.
Finding the top clinical trial analytics providers in contract manufacturing
Clinical Trials Arena has listed the top clinical trial analytical services providers in contract manufacturing based on its intel, insights, and decades-long experience in the sector. The list includes companies that provide various products and services, including:
- Analytical method transfer
- Assay and impurities testing
- Microbial testing
- Release testing
- Stability testing
The list also includes suppliers of advanced clinical data analytics platforms for more transparent processing of data and to facilitate the development of new clinical trial approaches.
The information contained within the download document is intended for clinical trial designers, clinical trial validation experts, principal investigators, and any other individual involved in the analysis of clinical trial data.
The document contains detailed information on the suppliers and their product and service offerings, alongside contact details to aid your purchasing or hiring decision.
Importance of clinical trial analytical testing
Analytical testing is a critical part of the clinical trial process as it ensures the safety and effectiveness of drug products while also ensuring that the strict requirements of regulatory bodies are met. The testing process needs to be tailored to the specific requirements of the drug development process and delivered on time to ensure the successful launch of clinical trials.
Outsourcing clinical trial analytics services to contract research organisations (CROs) and contract development and manufacturing organisations (CDMOs) is often undertaken by pharmaceutical companies as many of them lack in-house expertise.